Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company established in 2017. The company is dedicated to advancing superior treatments for brain disease, operating within the Health and Wellness, Medical Devices, and Pharmaceutical industries. In October 2021, Chase Therapeutics secured a significant $20.00M Series B investment from Brain Trust Accelerator Fund and China Link Capital.
General Information
Get notified when CHASE THERAPEUTICS moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CHASE THERAPEUTICS
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health and Wellness
About CHASE THERAPEUTICS
Taxonomy: specialty pharmaceuticals, brain disease, treatment development, early-stage, product-based, neurology, pharmaceutical company, medical innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 2 |
|
20 Oct 2021 |
| Venture Round | •••••• | 2 |
|
29 Oct 2019 |
| Series A | •••••• | - | 28 Aug 2018 | |
| Series A | •••••• | - | 21 Nov 2017 |
FAQ About CHASE THERAPEUTICS
We're actively collecting intelligence on CHASE THERAPEUTICS.
Track CHASE THERAPEUTICS to get notifiedDon't just browse. Track.
Signal Tracker monitors CHASE THERAPEUTICS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.